Events
Every year for the last 32 years, Enrst & Young has awarded entrepreneurs in various categories, including Life Science, Consumer Products and Retail, Distribution and Manufacturing and other categories. The awards are given in June. The finalists have been announced. Here’s a look at some of the finalists and semi-finalists.
Shares of Allergan have been in decline for more than a year and that has created an opening for some investors to begin rattling sabers about change at the company.
Sangamo Therapeutics recently filed a notice with the U.S. Securities and Exchange Commission (SEC) describing a data security breach. The incident underlines what appears to be a trend of cyber thieves attacking the biopharma industry.
General Electric is diving deeper into the world of biotechnology. The conglomeration is launching prefabricated manufacturing units to product virus-based gene and cell therapies, Reuters reported this morning.
Sanofi has agreed to sell its generics division, Zentiva, to Advent International. The deal is expected to wrap by the end of this year.
Mylan Rumored to be in Discussions to Buy Merck KGaA’s Consumer Health Business, but Mylan Denies It
Mylan is reportedly in top-level talks with Germany’s Merck KGaA to buy its consumer health business. However, Mylan has denied it.
Storm-tossed Theranos continues to get battered from the continued fallout from the myriad of self-inflicted problems it has faced over the past few years. Now the company has reportedly laid off an additional 100 employees as it strives to avoid shutting down from bankruptcy.
Pfizer has signed a 20-year lease for its new company global headquarters. It will be, as reported earlier, at The Spiral, an office tower being built by Tishman Speyer at 66 Hudson Boulevard at Hudson Yards of Manhattan.
It’s no secret that drugmakers have struggled to develop a therapeutic to treat or halt the onset of Alzheimer’s disease. Multiple drugs have failed in late-stage trials and some companies, such as Pfizer, have largely given up on the space.
More than a dozen advertisers, including Johnson & Johnson and Bayer, have boycotted the Fox News show, “The Ingraham Angle,” after its host, Laura Ingraham, 54, bullied high school student David Hogg.
PRESS RELEASES